Two studies of nerve growth factor (NGF) inhibitors implemented a rigorous mitigation plan to exclude osteoarthritis patients with a risk of joint collapse, but it was still not enough

Two studies of nerve growth factor (NGF) inhibitors implemented a rigorous mitigation plan to exclude osteoarthritis patients with a risk of joint collapse, but it was still not enough

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Osteoarthritis and cartilage 2024-12, Vol.32 (12), p.1518-1521
1. Verfasser: Guermazi, Ali
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1521
container_issue 12
container_start_page 1518
container_title Osteoarthritis and cartilage
container_volume 32
creator Guermazi, Ali
description
doi_str_mv 10.1016/j.joca.2024.08.011
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3101232552</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1063458424013669</els_id><sourcerecordid>3101232552</sourcerecordid><originalsourceid>FETCH-LOGICAL-c237t-3a3f31b2b025316d58fc64043f9b7f55e612ea122671671f13d777217bfd75f23</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxiNERUvhBTigORaJpP4TJ7sSl6qiBalqL-VsOfZ41yGJg-104c14PBxt4YhkyR7pm2_m868o3lFSUUKby77qvVYVI6yuyKYilL4ozqhgrNw2gr_Mb9Lwshab-rR4HWNPCOGUklfFKd8y3hImzorfjwcPMS3GYQRvYcLwhLAL_pD2YJVOPsDF_e3NB3DT3nUu1xHcOA844pTQgILgdj74JcLoktup5PwE86AmSB7wpx4Wg-BjQq9C2oesiTBnVW6PcHB5zGoRv6_Te--mBNoPg5ojfoRuSeASHFTMO7phgMknwMkvu_2b4sSqIeLb5_u8-Hbz-fH6S3n3cPv1-uqu1DliKrniltOOdTktp40RG6ubmtTcbrvWCoENZagoY01L87GUm7ZtGW07a1phGT8vLo6-c_A_FoxJji5qzBtOmENLnlEwzoRYpewo1cHHGNDKObhRhV-SErkSk71cicmVmCQbmYnlpvfP_ks3ovnX8hdRFnw6CjCnfHIYZNT58zQaF1Anabz7n_8flo6qTA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3101232552</pqid></control><display><type>article</type><title>Two studies of nerve growth factor (NGF) inhibitors implemented a rigorous mitigation plan to exclude osteoarthritis patients with a risk of joint collapse, but it was still not enough</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Guermazi, Ali</creator><creatorcontrib>Guermazi, Ali</creatorcontrib><identifier>ISSN: 1063-4584</identifier><identifier>ISSN: 1522-9653</identifier><identifier>EISSN: 1522-9653</identifier><identifier>DOI: 10.1016/j.joca.2024.08.011</identifier><identifier>PMID: 39237025</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Osteoarthritis and cartilage, 2024-12, Vol.32 (12), p.1518-1521</ispartof><rights>2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c237t-3a3f31b2b025316d58fc64043f9b7f55e612ea122671671f13d777217bfd75f23</cites><orcidid>0000-0002-9374-8266</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1063458424013669$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39237025$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Guermazi, Ali</creatorcontrib><title>Two studies of nerve growth factor (NGF) inhibitors implemented a rigorous mitigation plan to exclude osteoarthritis patients with a risk of joint collapse, but it was still not enough</title><title>Osteoarthritis and cartilage</title><addtitle>Osteoarthritis Cartilage</addtitle><issn>1063-4584</issn><issn>1522-9653</issn><issn>1522-9653</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kc9u1DAQxiNERUvhBTigORaJpP4TJ7sSl6qiBalqL-VsOfZ41yGJg-104c14PBxt4YhkyR7pm2_m868o3lFSUUKby77qvVYVI6yuyKYilL4ozqhgrNw2gr_Mb9Lwshab-rR4HWNPCOGUklfFKd8y3hImzorfjwcPMS3GYQRvYcLwhLAL_pD2YJVOPsDF_e3NB3DT3nUu1xHcOA844pTQgILgdj74JcLoktup5PwE86AmSB7wpx4Wg-BjQq9C2oesiTBnVW6PcHB5zGoRv6_Te--mBNoPg5ojfoRuSeASHFTMO7phgMknwMkvu_2b4sSqIeLb5_u8-Hbz-fH6S3n3cPv1-uqu1DliKrniltOOdTktp40RG6ubmtTcbrvWCoENZagoY01L87GUm7ZtGW07a1phGT8vLo6-c_A_FoxJji5qzBtOmENLnlEwzoRYpewo1cHHGNDKObhRhV-SErkSk71cicmVmCQbmYnlpvfP_ks3ovnX8hdRFnw6CjCnfHIYZNT58zQaF1Anabz7n_8flo6qTA</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Guermazi, Ali</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9374-8266</orcidid></search><sort><creationdate>202412</creationdate><title>Two studies of nerve growth factor (NGF) inhibitors implemented a rigorous mitigation plan to exclude osteoarthritis patients with a risk of joint collapse, but it was still not enough</title><author>Guermazi, Ali</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c237t-3a3f31b2b025316d58fc64043f9b7f55e612ea122671671f13d777217bfd75f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guermazi, Ali</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Osteoarthritis and cartilage</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guermazi, Ali</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Two studies of nerve growth factor (NGF) inhibitors implemented a rigorous mitigation plan to exclude osteoarthritis patients with a risk of joint collapse, but it was still not enough</atitle><jtitle>Osteoarthritis and cartilage</jtitle><addtitle>Osteoarthritis Cartilage</addtitle><date>2024-12</date><risdate>2024</risdate><volume>32</volume><issue>12</issue><spage>1518</spage><epage>1521</epage><pages>1518-1521</pages><issn>1063-4584</issn><issn>1522-9653</issn><eissn>1522-9653</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>39237025</pmid><doi>10.1016/j.joca.2024.08.011</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-9374-8266</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1063-4584
ispartof Osteoarthritis and cartilage, 2024-12, Vol.32 (12), p.1518-1521
issn 1063-4584
1522-9653
1522-9653
language eng
recordid cdi_proquest_miscellaneous_3101232552
source Elsevier ScienceDirect Journals Complete
title Two studies of nerve growth factor (NGF) inhibitors implemented a rigorous mitigation plan to exclude osteoarthritis patients with a risk of joint collapse, but it was still not enough
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T19%3A28%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Two%20studies%20of%20nerve%20growth%20factor%20(NGF)%20inhibitors%20implemented%20a%20rigorous%20mitigation%20plan%20to%20exclude%20osteoarthritis%20patients%20with%20a%20risk%20of%20joint%20collapse,%20but%20it%20was%20still%20not%20enough&rft.jtitle=Osteoarthritis%20and%20cartilage&rft.au=Guermazi,%20Ali&rft.date=2024-12&rft.volume=32&rft.issue=12&rft.spage=1518&rft.epage=1521&rft.pages=1518-1521&rft.issn=1063-4584&rft.eissn=1522-9653&rft_id=info:doi/10.1016/j.joca.2024.08.011&rft_dat=%3Cproquest_cross%3E3101232552%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3101232552&rft_id=info:pmid/39237025&rft_els_id=S1063458424013669&rfr_iscdi=true